Soleus Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$40.3M	Sell	1,726,908 -520,202	-23%	-$11.3M	1.63%	17
2025 Q4	$47.2M	Buy	2,247,110 +235,000	+12%	+$4.1M	1.74%	14
2025 Q3	$31M	Buy	2,012,110 +920,000	+84%	+$12M	1.56%	21
2025 Q2	$10.2M	Buy	1,092,110 +275,500	+34%	+$3.03M	0.68%	38
2025 Q1	$10M	Sell	816,610 -1,675,390	-67%	-$23.6M	0.72%	37
2024 Q4	$32.9M	Buy	2,492,000 +1,401,016	+128%	+$24M	2.07%	15
2024 Q3	$21M	Buy	1,090,984 +264,484	+32%	+$5.46M	1.63%	20
2024 Q2	$17M	Buy	826,500 +457,500	+124%	+$9.57M	1.5%	26
2024 Q1	$8.78M	Sell	369,000 -145,000	-28%	-$3.23M	0.65%	47
2023 Q4	$11.1M	Buy	514,000 +394,500	+330%	+$6.06M	1.23%	26
2023 Q3	$1.74M	Sell	119,500 -93,100	-44%	-$1.76M	0.16%	71
2023 Q2	$4.45M	Sell	212,600 -110,000	-34%	-$2.29M	0.49%	51
2023 Q1	$6.81M	Buy	322,600 +102,600	+47%	+$2.55M	0.71%	41
2022 Q4	$5.6M	Buy	+220,000	New	+$5.13M	0.8%	36
2020 Q2	–	Sell	-20,980	Closed	-$230K	–	68
2020 Q1	$230K	Hold	20,980	–	–	0.27%	42
2019 Q4	$184K	Buy	+20,980	New	+$154K	0.18%	49